<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<title>My (evidence-based) approach to post MI VT</title>
<meta name="author" content="(Raja Selvaraj, JIPMER)"/>
<style type="text/css">
.underline { text-decoration: underline; }
</style>

<link rel="stylesheet" href="/js/reveal.js/css/reveal.css"/>

<link rel="stylesheet" href="/js/reveal.js/css/theme/beige.css" id="theme"/>

<link rel="stylesheet" href="./local.css"/>

<!-- If the query includes 'print-pdf', include the PDF print sheet -->
<script>
    if( window.location.search.match( /print-pdf/gi ) ) {
        var link = document.createElement( 'link' );
        link.rel = 'stylesheet';
        link.type = 'text/css';
        link.href = '/js/reveal.js/css/print/pdf.css';
        document.getElementsByTagName( 'head' )[0].appendChild( link );
    }
</script>
</head>
<body>
<div class="reveal">
<div class="slides">
<section id="sec-title-slide"><h1 class="title">My (evidence-based) approach to post MI VT</h1><h2 class="author">Raja Selvaraj, JIPMER</h2>
</section>


<section>
<section id="slide-orgheadline4">
<h2 id="orgheadline4">Introduction</h2>
<div class="outline-text-2" id="text-orgheadline4">
</div></section>
</section>
<section>
<section id="slide-orgheadline1">
<h3 id="orgheadline1">Not covering</h3>
<ul>
<li>Acute management</li>
<li>non-device management</li>
<li>non sustained VT</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline2">
<h3 id="orgheadline2">Covering</h3>
<ul>
<li class="fragment appear">Sustained VT late after MI
<ul>
<li>severe LV dysfunction</li>
<li>mild LV dysfunction</li>

</ul></li>

<li class="fragment appear">VT/VF early after MI
<ul>
<li>within 48 hours</li>
<li>after 48 hours</li>

</ul></li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline3">
<h3 id="orgheadline3">Guidelines</h3>
<ul>
<li>ACC / AHA practice guidelines - 2008 (2012 update)</li>
<li>ACCF / AHA / HRS Appropriate use criteria 2013</li>

</ul>
<aside class="notes">
<p>
Appropriate use criteria complement practice guidelines.
More real-life scenarios and cover situations where there is not much evidence.
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline15">
<h2 id="orgheadline15">Ventricular arrhythmias early after MI</h2>
<div class="outline-text-2" id="text-orgheadline15">
</div></section>
</section>
<section>
<section id="slide-orgheadline5">
<h3 id="orgheadline5">Scenario</h3>
<ul>
<li>36 male</li>
<li>VF on second day - defibrillated</li>
<li>LVEF 30%</li>
<li class="fragment appear">No indication as per guidelines</li>

</ul>
<aside class="notes">
<p>
Common scenario. Everyone agrees primary VF not considered indication for ICD.
</p>

</aside>


</section>
</section>
<section>
<section id="slide-orgheadline6">
<h3 id="orgheadline6">Rationale</h3>
<ul>
<li>Related to reversible trigger</li>
<li>Does not affect long term outcome</li>
<li>ICD implant not indicated on this basis</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline7">
<h3 id="orgheadline7">Not benign !</h3>
<ul>
<li class="fragment appear">AIVR - benign</li>
<li class="fragment appear">Primary VF - poor acute outcome</li>
<li class="fragment appear">But does not impact long term outcome</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline8">
<h3 id="orgheadline8">Fast MI registry - 5 year analysis of outcomes</h3>

<div class="figure">
<p><img src="images/fast_mi_front.png" alt="fast_mi_front.png" />
</p>
</div>
<aside class="notes">
<p>
French registry of patients with AMI.
Provides best longitudinal data on these patients
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline9">
<h3 id="orgheadline9">Higher early mortality</h3>

<div class="figure">
<p><img src="images/fast_mi_early_mortality.png" alt="fast_mi_early_mortality.png" />
</p>
</div>
<aside class="notes">
<p>
In hospital mortality is high
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline10">
<h3 id="orgheadline10">Long term outcome not affected</h3>

<div class="figure">
<p><img src="images/fast_mi_late_mortality.png" alt="fast_mi_late_mortality.png" />
</p>
</div>
<aside class="notes">
<p>
But long term survival not different
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline11">
<h3 id="orgheadline11">Appropriate use criteria</h3>

<div class="figure">
<p><img src="images/appropriate_early_vt.png" alt="appropriate_early_vt.png" />
</p>
</div>
<aside class="notes">
<p>
However, clearly there is apprehension about sudden death risk, especially early
AUC suggest possible role for ICD when 
</p>
<ul>
<li>EF is low</li>
<li>Recurrent VF</li>
<li>Persistent NSVT</li>
<li>Inducible VT</li>
<li>revasculatization not possible</li>

</ul>

</aside>


</section>
</section>
<section>
<section id="slide-orgheadline12">
<h3 id="orgheadline12">Wearable defibrillator</h3>

<div class="figure">
<p><img src="images/wearable_defib.jpg" alt="wearable_defib.jpg" />
</p>
</div>
<aside class="notes">
<p>
Wearable defibrillator may play a role in these situations
Provide safety net for a period until decision regarding ICD is clearer
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline13">
<h3 id="orgheadline13">Summary</h3>
<ul>
<li>Aggressive short term management indicated</li>
<li>By itself not an indication for ICD implant</li>
<li>Can consider, especially with reduced EF, especially after revascularization</li>
<li>Role for wearable defibrillator</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline14">
<h3 id="orgheadline14">VT / VF after 48 hours</h3>
<ul>
<li>Secondary prevention indication</li>
<li>Need ICD implantation</li>
<li>No need to wait for secondary prevention</li>
<li>Indicator of extensive myocardial damage</li>
<li>Poor in-hospital outcome and 1 yr survival</li>

</ul>
<aside class="notes">
<p>
Sometimes there is confusion about 40 day waiting period.
Only applies to primary preevention.
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline29">
<h2 id="orgheadline29">Sustained VT late post MI</h2>
<div class="outline-text-2" id="text-orgheadline29">
</div></section>
</section>
<section>
<section id="slide-orgheadline16">
<h3 id="orgheadline16">Scenario</h3>
<ul>
<li>48 male</li>
<li>AWMI 4 years back</li>
<li>Presents with sustained VT / syncope / cardioversion</li>
<li>LVEF 35%</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline17">
<h3 id="orgheadline17">Management</h3>
<ul>
<li class="fragment appear">ICD</li>
<li class="fragment appear">Antiarrhythmic drugs / RF ablation ?</li>
<li class="fragment appear">CAG ?</li>
<li class="fragment appear">Single / dual chamber device?</li>
<li class="fragment appear">Single coil / dual coil ?</li>
<li class="fragment appear">Defibrillation threshold testing ?</li>

</ul>
<aside class="notes">
<p>
Everyone will agree with clear indication for ICD
Many other questions remain
I will not be covering last three
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline18">
<h3 id="orgheadline18">ICD implantation</h3>
<ul>
<li>Guidelines
<ul>
<li>Class I A - Cardiac arrest due to VF / unstable VT</li>
<li>Class I B - Stable or unstable VT</li>

</ul></li>

</ul>
<aside class="notes">
<p>
VT late post MI is a class I indication
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline19">
<h3 id="orgheadline19">Evidence</h3>
<p>
<img src="images/metaanalysis_mortality.png" alt="metaanalysis_mortality.png" />
Ref: Connolly et al. Metaanalysis of ICD secondary prevention trials
</p>
<aside class="notes">
<p>
AVID, CIDS, CASH are major trials
AVID largest, but was stopped early
Meta analysis provides better power
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline20">
<h3 id="orgheadline20">CAG</h3>
<ul>
<li>Polymorphic VT / VF can be due to reversible ischemia</li>
<li>Sustained monomorphic VT not due to ischemia</li>
<li>Modest elevation of biomarkers does not indicate ischemia</li>
<li>Re test after 3 months if possibly reversible after revascularization</li>

</ul>
<aside class="notes">
<p>
If there is suggestion of ischemia as a (reversible) trigger, CAG and revascularize
But monomorphic VT is almost never due to ischemia
Elevation of markers by itself doesnt indicate ischemia
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline21">
<h3 id="orgheadline21">Anti-arrhythmic drugs</h3>
<ul>
<li>ICD does not prevent VT</li>
<li>ICD is not a treament for VT</li>
<li>Amiodarone reduces recurrences, low proarrhythmic risk</li>
<li>But amiodarone doesn't save lives</li>

</ul>


</section>
</section>
<section>
<section id="slide-orgheadline22">
<h3 id="orgheadline22">Ablation</h3>
<ul>
<li>Significant reduction in recurrences when used as first line</li>
<li>Superior to AAD with failed amio</li>
<li>Does not reduce mortality</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline23">
<h3 id="orgheadline23">Ablation as first line</h3>

<div class="figure">
<p><img src="images/vtach_front.png" alt="vtach_front.png" />
</p>
</div>

</section>
</section>
<section>
<section id="slide-orgheadline24">
<h3 id="orgheadline24">Ablation as first line</h3>

<div class="figure">
<p><img src="images/vtach_results.png" alt="vtach_results.png" />
</p>
</div>
<aside class="notes">
<p>
VTACH supports ablation as frontline therapy
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline25">
<h3 id="orgheadline25">Ablation after recurrence on AAD</h3>

<div class="figure">
<p><img src="images/escalated_front.png" alt="escalated_front.png" />
</p>
</div>

</section>
</section>
<section>
<section id="slide-orgheadline26">
<h3 id="orgheadline26">Ablation after recurrence on AAD</h3>

<div class="figure">
<p><img src="images/escalated_result.png" alt="escalated_result.png" width="600px" />
</p>
</div>
<aside class="notes">
<p>
If not done at beginning, ablation should be done after a recurrence
Better than drug escalation
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline27">
<h3 id="orgheadline27">Ablation after recurrence on AAD</h3>

<div class="figure">
<p><img src="images/escalated_amio.png" alt="escalated_amio.png" width="400px" />
</p>
</div>
<aside class="notes">
<p>
If patient is not on amio, start on amio
But if on amio already, abl better than increasing dose / adding another drug
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline28">
<h3 id="orgheadline28">Summary</h3>
<ul>
<li>ICD implantation indicated</li>
<li>Need AAD / RFA to reduce recurrences</li>
<li>Amiodarone AAD of choice</li>
<li>If AAD chosen initially, RFA for recurrence</li>

</ul>


</section>
</section>
<section>
<section id="slide-orgheadline36">
<h2 id="orgheadline36">Sustained VT late post MI with mild LV dysfunction</h2>
<div class="outline-text-2" id="text-orgheadline36">
</div></section>
</section>
<section>
<section id="slide-orgheadline30">
<h3 id="orgheadline30">Scenario 3</h3>
<ul>
<li>54 male</li>
<li>IWMI 6 years back</li>
<li>walk-in VT</li>
<li>LVEF 45%</li>

</ul>
<aside class="notes">
<p>
Not uncommon scenario
Not well represented in trials
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline31">
<h3 id="orgheadline31">What do the guidelines say?</h3>
<ul>
<li>Hemodynamically unstable sustained VT / VF - class I A</li>
<li>Structural heart disease, stable sustained VT - class I B</li>
<li>Sustained VT with normal or near normal LV function - class IIa C</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline32">
<h3 id="orgheadline32">ICD secondary prevention trials metaanalysis</h3>
<ul>
<li>29 implants to save one life per year of follow up</li>
<li>Benefit after 3 years?</li>
<li>Increase in survival by 1/3 years after 6 years of follow up</li>

</ul>
<aside class="notes">
<p>
First, the benefit even in secondary prevention trials is not huge
And curves stop diverging at 3 yrs
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline33">
<h3 id="orgheadline33">Importance of EF</h3>

<div class="figure">
<p><img src="images/metaanalysis_ef.png" alt="metaanalysis_ef.png" />
</p>
</div>
<aside class="notes">
<p>
And if you factor in EF, there is no benefit when EF is more than 35%
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline34">
<h3 id="orgheadline34">Beta blockers in secondary prevention</h3>

<div class="figure">
<p><img src="images/metaanalysis_baseline.png" alt="metaanalysis_baseline.png" width="600px" />
</p>
</div>

<p>
Ref: Connolly et al. Metaanalysis of ICD secondary prevention trials
</p>
<aside class="notes">
<p>
And this is likely to be more true with current management
In these early trials, beta blocker use was abysmally low 
and was unbalanced among the groups in AVID
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline35">
<h3 id="orgheadline35">Appropriate use criteria</h3>

<div class="figure">
<p><img src="images/stable_vt.png" alt="stable_vt.png" />
</p>
</div>
<aside class="notes">
<p>
If LV dysfunction is not severe,
and ablation can be done with no inducible VT at end,
ICD may be withheld
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline37">
<h2 id="orgheadline37">Summary - My approach</h2>
<ul>
<li>Remote MI, severe LV dysfunction, VT/VF - ICD</li>
<li>Remote MI, moderate LV dysfunction, VT - AAD / abl, ICD</li>
<li>Reducing recurrence - AAD as first line</li>
<li>Recurrence on AAD - Ablation rather than escalate</li>
<li>Lot of grey areas, weigh evidence, involve patient in decision making</li>

</ul>
</section>
</section>
</div>
</div>
<script src="/js/reveal.js/lib/js/head.min.js"></script>
<script src="/js/reveal.js/js/reveal.js"></script>

<script>
// Full list of configuration options available here:
// https://github.com/hakimel/reveal.js#configuration
Reveal.initialize({

controls: true,
progress: true,
history: false,
center: true,
slideNumber: 'c',
rollingLinks: true,
keyboard: true,
overview: true,
width: 1200,
height: 800,
margin: 0.10,
minScale: 0.50,
maxScale: 2.00,

theme: Reveal.getQueryHash().theme, // available themes are in /css/theme
transition: Reveal.getQueryHash().transition || 'fade', // default/cube/page/concave/zoom/linear/fade/none
transitionSpeed: 'default',
multiplex: {
    secret: '', // null if client
    id: '', // id, obtained from socket.io server
    url: '' // Location of socket.io server
},

// Optional libraries used to extend on reveal.js
dependencies: [
 { src: '../reveal.js/plugin/notes/notes.js', async: true, condition: function() { return !!document.body.classList; } }]
});
</script>
</body>
</html>
